SMAD3 and exfoliation syndrome: This feedback loop between ATG5 and TGF-β1 is possibly mediated via miR-122-5p and Smad3 pathway, which may be a therapeutic target to reduce EMT, fibrosis, and prevent or reduce aggregate formation in XFS.